Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
K-V Pharmaceutical Co
| Metric | K-V Pharmaceutical Co Healthcare |
|---|---|
| Quality Score | 17 / 100 |
| Revenue (latest) | $23M |
| Net income (latest) | −$102M |
| Operating margin | −608.6% |
| Net margin | −440.9% |
| Return on equity | 21.3% |
| Return on assets | −40.4% |
| Return on capital (ROCE) | −173.5% |
| Debt / equity | — |
| Revenue growth (YoY) | −15.0% |
| Altman Z″ (distress) | -14.27 |
| Accruals / assets | 26.4% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.